Table 1.
Patient and Tumor Characteristics
| Variable | All Patients (n=121) Value or No. (%) |
|---|---|
| Follow-up time, months | |
| Median | 100 |
| Range | 20–462 |
| Age, years | |
| Median | 57 |
| Range | 20–77 |
| Sex | |
| Male | 63 (52) |
| Female | 58 (48) |
| Maximum Tumor Dimension, cm | |
| Median | 10.3 |
| Range | 1.7–36 |
| Tumor size | |
| ≤ 5 cm | 13 (11) |
| > 5 cm | 107 (88) |
| Unknown | 1 (1) |
| Grade | |
| Low | 17 (14) |
| Intermediate | 22 (18) |
| High | 82 (68) |
| Histopathology | |
| Liposarcoma | 42 (34) |
| MFH/UPS | 34 (28) |
| Leiomyosarcoma | 28 (23) |
| Unclassified | 8 (6) |
| Other | 11 (9) |
| De novo at presentation | |
| Yes | 86 (71) |
| No | 35 (29) |
| Treatment Approach | |
| Preop RT | 88 (73) |
| Postop RT | 33 (27) |
| Final Surgical Resection Margin | |
| Positive/Uncertain | 63 (52) |
| Negative | 58 (48) |
| Radiation | |
| EBRT only | 100 (82) |
| EBRT + IORT | 19 (16) |
| EBRT + Brachy | 1 (1) |
| Brachy only | 1 (1) |
| Radiation Dose, Gy | |
| Median | 50.4 |
| Range | 45–56 |
| Chemotherapy | |
| Neo/Adj | 61 (50) |
| CCRT | 17 (14) |
Abbreviations: MFH/UPS, malignant fibrous histiocytoma/unclassified pleomorphic sarcoma; RT, radiation therapy; EBRT, external beam radiation therapy; IORT, intraoperative radiation therapy; Neo/Adj, neoadjuvant/adjuvant; CCRT, concurrent chemoradiation.